器官移植后糖尿病研究进展

www.yongyao.net　　2009-8-10 10:43:32　　来源：　　责任编辑：

分享到：

参考文献
[1] Hjelmesaeth J, Jenssen T, Hartmann A. Diagnosing PTDM[J]. Transplantation,2003, 75( 10) : 1761.
[2] Hoban R, Gielda B, Temkit M. Utility of HbA1c in the detection of subclinical post renal transplant diabetes[J].Transplantation, 2006, 81( 3) : 379- 383.
[3] Schiel R, Heinrich S, Steiner T. Post - transplant diabetes mellitus:risk factors, frequency of transplant rejections, and long- term prognosis[J]. Clin Exp Nephrol, 2005, 9( 2) : 164- 169.
[4] Rodrigo E, CosMA, Fernandez- FresnedoG. Higher initial tacrolimus blood levels and concentration- dose ratios in kidney transplant recipients who develop diabetes mellitus[J]. Transplant Proc, 2005, 37( 9) : 3819- 3820.
[5] Penfornis A, Kury- Paulin S. Immunosuppressive drug- induced diabetes[J]. Diabetes Metab, 2006, 32( 5 Pt 2) : 539- 546.
[6] Bloom RD, Rao V,Weng R, et al. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus[J].J AmSoc Nephrol, 2002, 13( 5) : 1374- 1380.
[7] AlDosary AA, Ramji AS, Elliott TG, et al. Post - Liver Transplantation diabetes mellitus: an association with hepatitis C[J]. Liver Transplantation,2002, 8( 4) : 356- 361.
[8] Parilkh CR, KlemP,Wong C. Obesity as an independent predictor of posttransplant diabetes mellitus [J]. Transplant Proc, 2003, 35( 8) :2922- 2926.
[9] Sezer S, Bilgic A, Uyar M. Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients [J]. TransplantProc, 2006, 38( 2) : 529- 532.
[10] Kang ES, Kim MS, Kim YS. A variant of the transcription factor 7-like 2 ( TCF7L2) gene and the risk of post- transplant diabetes mellitus( PTDM) in renal allograft recipients [J]. Diabetes Care,2008, 31( 1) : 63- 68.
[11] Hagenl M, Hjelmesth J, Jenssenl T, et al. A 6- year prospective study on newonset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients [J]. Nephrol Dial Transplant,2003, 18( 10) : 2154- 2159
[12] Kyu YH, Myoung SK, Yu SK, et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients[J]. Diabetes Care, 2007, 30( 3) : 609- 615.
[13] Panz VR, Bonegio R, Raal FJ, et al. Diabetogenic efect of tacrolimus in South African patients undergoing kidney transplantation [J].Transplantation, 2002, 73( 4) : 587- 590.
[14] Stockmann M, Konrad T. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after livingdonor liver transplantation[J]. Liver Transpl, 2006, 12( 4) : 535- 543.
[15] Revanur VK, Jardine AG, Kingsmore DB. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation[J]. Clin Transplant,2001, 15( 2) : 89- 94.
[16] Gonzalez- Posada JM, Hernandez D, Genis BB. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post - transplant diabetes mellitus in Spain [J]. Clin Transplant.2006, 20( 5) : 650- 658.
[17] Hor T, Baldwin D. Urinary albumin excretion in patients with diabetes after renal transplantation [J]. Transplant Proc, 2006, 38( 9) :2879- 2882.
[18] Gonzalez- Posada JM, Hernandez D, Bayes Genis B, et al. Impact of diabetes mellitus on kidney transplant recipients in Spain [J].Nephrol Dial Transplant, 2004, 19( suppl 3) : iii57- 61.
[19] Jaber JJ, Feustel PJ, Elbahloul O, et al. Early steroid withdrawal therapy in renal transplant recipients: a steroid - free sirolimus and CellCept- based calcineurin inhibitor- minimization protocol[J]. ClinTransplant, 2007, 21( 1) : 101- 109.
[20] Ramos- Cebrián M, Torregrosa JV, Gutiérrez- Dalmau A. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation [J]. TransplantProc, 2007, 39( 7) : 2251- 2253.
[21]Wyzgal J, Paczek L, Ziolkowski J, et al. Early hyperglycemia after allogenic kidney transplantation [J]. Ann Transplant, 2007, 12( 1) :40- 45.
[22] Shishido S, Sato H, Asanuma H. Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients[J]. Pediatr Transplant, 2006, 10( 1) : 67- 73.
[23] Duclos A, Flechner LM, Faiman C. Post - transplant diabetes mellitus:risk reduction strategies in the elderly[J]. Drugs Aging, 2006, 23( 10) : 781- 793.
[24] Sezer S, Akgul A, Altinoglu A. Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome[J]. Transplant Proc, 2006, 38( 2) : 533- 536.
[25] Turk T, Pietruck F, Dolffa S, et al. Repaglinide in the management of new- onset diabetes mellitus after renal transplantation [J]. Am JTransplant, 2006, 6( 4) : 842- 846.